Novo Nordisk A/S (NVO)

62.33 +5.21 (+9.12%) USD  |  NYSE  |  Jan 16, 16:00
62.80 +0.47 (+0.75%) After-Hours: 20:00
More

Novo Nordisk Total Long Term Liabilities (Quarterly)

Total Long Term Liabilities (Quarterly) Chart

View Total Long Term Liabilities (Quarterly) for NVO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Liabilities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Liabilities (Quarterly) Range, Past 5 Years

View Total Long Term Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Liabilities (Quarterly) Benchmarks

View Total Long Term Liabilities (Quarterly) Benchmarks
Start Trial
Ascendis Pharma A/S Upgrade
Evaxion AS --
Regeneron Pharmaceuticals, Inc. --
Omeros Corp. --
Viking Therapeutics, Inc. --